The University of Chicago Header Logo

Connection

Jessica J. Kandel to Half-Life

Back to Details
This is a "connection" page, showing publications Jessica J. Kandel has written about Half-Life.
Jessica J. Kandel
Connection Strength
0.019
Half-Life
  1. Phase I trial and pharmacokinetic study of bevacizumab in pediatric patients with refractory solid tumors: a Children's Oncology Group Study. J Clin Oncol. 2008 Jan 20; 26(3):399-405.
    View in: PubMed
    Score: 0.019
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.